Republic Healthcare Limited (HK:8357)

:8357

8357

Republic Healthcare Limited

RESEARCH TOOLSreports

Want to see HK:8357 full AI Analyst Report?

Republic Healthcare Limited (8357) Price & Analysis

0 Followers

8357 Stock Chart & Stats

HK$0.12

HK$0.00(0.00%)

At close: Jan 03 4:00 PM EST

HK$0.12

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.07 - HK$0.24

Previous CloseN/A

Volume50.00K

Average Volume (3M)282.67K

Market Cap

HK$63.65M

Enterprise ValueHK$8.89M

Total Cash (Recent Filing)HK$9.75M

Total Debt (Recent Filing)HK$1.25M

Price to Earnings (P/E)―

Beta0.33

Next Earnings

Jul 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding624,000,000

10 Day Avg. Volume457,500

30 Day Avg. Volume282,666

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.51

Price to Sales (P/S)1.84

P/FCF Ratio-4.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Historical Low LeverageA multi-year record of low leverage (2021–2024) indicates the company previously maintained financial flexibility and capacity to absorb shocks. That history supports access to financing and operational resiliency over the medium term, easing recovery if earnings stabilize.

Equity CushionA sizable equity base relative to assets provides a persistent solvency buffer that can absorb continued losses and support operations without immediate liquidation. This cushion reduces insolvency risk and supports longer-term strategic options.

Defensive Industry ExposureOperating in medical care facilities creates structurally recurring demand driven by healthcare needs and aging populations. This defensive demand profile supports more stable long-term revenue potential and improves recovery prospects once operational issues are addressed.

Bears Say

Deteriorating ProfitabilityA transition to a gross loss and large operating/net losses materially weakens earnings quality and reduces reinvestment capacity. Persistent unprofitability erodes margins, damages competitive positioning, and increases the need for external capital to sustain operations.

Negative Cash FlowNegative operating and free cash flow undermines liquidity and the company’s ability to fund day-to-day operations internally. Over months, this forces reliance on debt or equity raises, increases financing costs and constrains capital expenditures or service expansion.

Rising Leverage In 2025A marked increase in debt during a period of deeper losses raises leverage and interest burden, reducing financial flexibility. Higher leverage with negative earnings elevates default and covenant risks and limits the firm's ability to invest or respond to adverse shocks.

8357 FAQ

What was Republic Healthcare Limited’s price range in the past 12 months?

Republic Healthcare Limited lowest stock price was HK$0.07 and its highest was HK$0.24 in the past 12 months.

What is Republic Healthcare Limited’s market cap?

Republic Healthcare Limited’s market cap is HK$63.65M.

When is Republic Healthcare Limited’s upcoming earnings report date?

Republic Healthcare Limited’s upcoming earnings report date is Jul 31, 2026 which is in 57 days.

How were Republic Healthcare Limited’s earnings last quarter?

Republic Healthcare Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.017.

Is Republic Healthcare Limited overvalued?

According to Wall Street analysts Republic Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Republic Healthcare Limited pay dividends?

Republic Healthcare Limited does not currently pay dividends.

What is Republic Healthcare Limited’s EPS estimate?

Republic Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Republic Healthcare Limited have?

Republic Healthcare Limited has 624,000,000 shares outstanding.

What happened to Republic Healthcare Limited’s price movement after its last earnings report?

Republic Healthcare Limited reported an EPS of -HK$0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.759%.

Which hedge fund is a major shareholder of Republic Healthcare Limited?

Currently, no hedge funds are holding shares in HK:8357

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Republic Healthcare Limited

Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexual health and infectious diseases. It also provides treatment solutions for common skin conditions and basic medical aesthetics services. The company operates nine clinics under the Dr. Tan & Partners brand name; and one clinic under the S Aesthetics brand name. Republic Healthcare Limited was founded in 2010 and is headquartered in Singapore.